Integrated analysis reveals the dysfunction of intercellular communication and metabolic signals in dilated

Rui Shi1, Xiue Ma2, Mi Zhou3

  • 1Department of Obstetrics and Gynecology, East Hospital, Tongji University School of Medicine, Shanghai, China.

Heliyon
|March 4, 2024
PubMed

Insights

This study reveals key cell-cell communication and metabolic pathways involved in dilated cardiomyopathy. Understanding these signals offers potential new targets for treating this heart muscle condition.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Systems Biology

Background:

  • Dilated cardiomyopathy (DCM) is a heart muscle disease with diverse causes, leading to significant morbidity and mortality.
  • Despite advances in heart failure management, understanding DCM's underlying mechanisms remains crucial.

Purpose of the Study:

  • To analyze cell-cell communication characteristics in DCM.
  • To investigate metabolic signaling pathways in DCM.
  • To identify potential therapeutic targets for DCM.

Main Methods:

  • Integrated single-nucleus and bulk sequencing data from donor and DCM left ventricle samples.
  • Utilized CellChat for intercellular communication analysis.
  • Applied gene set enrichment analysis for metabolic pathway comparison.

Main Results:

  • Identified abnormal cell-to-cell signaling transduction and dysfunctional metabolic pathways in DCM.
  • Determined cell-type specific alterations in glucose, lipid, and amino acid metabolism.
  • Validated key signaling pathways (BMP, NOTCH) and arginine metabolism.

Conclusions:

  • Revealed critical signals and metabolic pathways crucial for DCM adaptation and progression.
  • Highlighted potential targets for therapeutic intervention in dilated cardiomyopathy.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...